IDT is a 50-year-old contract and development manufacturing organisation with expertise in translating medicine from bench to patient supporting the Australian clinical trial ecosystem. IDTs three pillars include API development and manufacture including high potent, solid oral dose formulation, tablet, capsule and liquid manufacturing and sterile fill and finish including complex formulations such as lyophilisation, lipid nanoparticle and antibody drug conjugate.